recombinant glp-1 Gibco™ Human Protein, PeproTech® in the 53 to 89 aa range Targeting GLP-1, GIP & GCG

C., Davinelli, S., & Scapagnini, G

ACS nano 8 (3), 29983005

Problem: severe nausea that does not improve Nausea that persists beyond 2 to 3 weeks at any dose level, or nausea severe enough to prevent eating for more than 24 hours, warrants medical attention

Evidence-based dietary advice, behavioural therapy, and multidisciplinary support may all help to minimize the impact of weight rebound after GBT treatment is stopped [131,147,150,157,158]

Compounded GLP-1s aren't registered with SAHPRA and aren't tested for quality or stability

Melanotan-II treatment resulted in weight loss but did not affect repetitive or anxiety-like behavior of normal C57BL/6J mice MC4R stimulation has been linked to increased stress behaviors based on its effects on the hypothalamic-pituitary-adrenal axis [41]